United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2015_register executive 2018-02-16 article Notices D09002ee1c7f80700 D09002ee1c7f80789 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a Start-Up Exclusive Patent License to Biohaven Pharmaceuticals Holding Company having its principal place of business in New Haven, Connecticut. The contemplated license would be for the inventions claimed in U.S. Utility Patent Number 8,859,585, issued October 14, 2014 (filed May 25, 2005), PCT Patent Application Number PCT/US2006/19335, filed May 18, 2006, U.S. Patent Application Number 14/478,442, filed September 5, 2014, European Patent Number 1896025, issued December 28, 2011 (and validated in Germany, France, and the United Kingdom), and Canadian Patent Number 2610025, issued July 22, 2014 (filed May 28, 2006). In addition, inventions claimed in any future applications claiming priority to or benefit of these patents and patent applications would also be subject to any license granted pursuant to this Notice. The patent rights in this invention have been assigned to the Government of the United States of America. The territory of the prospective Start-Up Exclusive Patent License Agreement may be worldwide and the field of use may be limited to use of scopolamine for treatment of neuropsychiatric indications. 80 FR 2951 https://www.govinfo.gov/app/details/FR-2015-01-21/2015-00811 2015-00811 fr21ja15-80 4140-01-P https://www.govinfo.gov/app/details/FR-2015-01-21/2015-00811 https://www.govinfo.gov/content/pkg/FR-2015-01-21/html/2015-00811.htm https://www.govinfo.gov/content/pkg/FR-2015-01-21/pdf/2015-00811.pdf 2 p. 2951 2952 80 FR 2951 Prospective Grant of Start-up Exclusive License: Scopolamine for the Treatment of Depression and Anxiety; Federal Register Vol. 80, Issue NOTICE 2015-00811 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2015-02-05 4140-01-P 2015-00811 Notice.

This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a Start-Up Exclusive Patent License to Biohaven Pharmaceuticals Holding Company having its principal place of business in New Haven, Connecticut. The contemplated license would be for the inventions claimed in U.S. Utility Patent Number 8,859,585, issued October 14, 2014 (filed May 25, 2005), PCT Patent Application Number PCT/US2006/19335, filed May 18, 2006, U.S. Patent Application Number 14/478,442, filed September 5, 2014, European Patent Number 1896025, issued December 28, 2011 (and validated in Germany, France, and the United Kingdom), and Canadian Patent Number 2610025, issued July 22, 2014 (filed May 28, 2006). In addition, inventions claimed in any future applications claiming priority to or benefit of these patents and patent applications would also be subject to any license granted pursuant to this Notice. The patent rights in this invention have been assigned to the Government of the United States of America. The territory of the prospective Start-Up Exclusive Patent License Agreement may be worldwide and the field of use may be limited to use of scopolamine for treatment of neuropsychiatric indications.

Only written comments and/or applications for a license that are received by the NIH Office of Technology Transfer on or before February 5, 2015 will be considered. Prospective Grants of Start-Up Exclusive Licenses: Scopolamine for the Treatment of Depression and Anxiety , anos@mail.nih.gov Vol. 80, no. 13 Office of the Federal Register, National Archives and Records Administration 2015-01-21 continuing daily deposited born digital 333 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2015-01-21 P0b002ee1987a7ecf 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr21ja15 https://www.govinfo.gov/app/details/FR-2015-01-21 https://www.govinfo.gov/content/pkg/FR-2015-01-21/pdf/FR-2015-01-21.pdf https://www.govinfo.gov/content/pkg/FR-2015-01-21/xml/FR-2015-01-21.xml fdlp 2813 3137 DGPO 2018-02-16 2024-06-02 FR-2015-01-21 machine generated eng FR FR-2015-01-21 80 13